Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in db/db Mice Using Cytokine Antibody Array

Figure 2

Renal pathological changes after 12-week treatment (PAS × 400). (a) Model group (expt. week 0); (b) control group (expt. week 0); (c) control group (expt. week 12); (d) model group (expt. week 12); (e) LST (losartan) group (expt. week 12); (f) TSF group (expt. week 12); (g) change of glomerular area, mesangial area, and the percentage of mesangial area. compared with control group in the same time point; compared with the model group at the same time point.

(a)

(b)

(c)

(d)

(e)

(f)

(g)